0 Comments
0 Shares
519 Views
0 Reviews
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
Monoclonal Antibodies Market See Incredible Growth 2022-2032 | Amgen Inc, Merck & Co Inc, AbbVie IncA recent study on the Monoclonal Antibodies market aims at leveraging the insights derived on the basis of both qualitative and quantitative data assessment for the forecast period, 2023-2032. The market intelligence report on Monoclonal Antibodies market dives deep into aspects including but not limited to the market size, growth and share across different regions to keep the stakeholders and...0 Comments 0 Shares 1K Views 0 Reviews
-
Monoclonal Antibodies Market See Incredible Growth 2022-2032 | Amgen Inc, Merck & Co Inc, AbbVie IncA recent study on the Monoclonal Antibodies market aims at leveraging the insights derived on the basis of both qualitative and quantitative data assessment for the forecast period, 2023-2032. The market intelligence report on Monoclonal Antibodies market dives deep into aspects including but not limited to the market size, growth and share across different regions to keep the stakeholders and...0 Comments 0 Shares 1K Views 0 Reviews
-
Monoclonal Antibodies (Mabs) Market by Top Manufacturers with Production, Price, Revenue & Region 2032“According to the research report, the global monoclonal antibodies in veterinary health market was valued at USD 785.71 million in 2022 and is expected to reach USD 3,425.91 million by 2032, to grow at a CAGR of 15.98% during the forecast period.” Market Overview: Polaris Market Research, a leading global market research company, has published an extensive research report...0 Comments 0 Shares 509 Views 0 Reviews
-
Monoclonal Antibodies (Mabs) Market Segmentation, Future Trends, Growth Overview, Key Companies and Forecast by 2032"According to the research report, the global monoclonal antibodies market was valued at USD 185.07 billion in 2021 and is expected to reach USD 479.13 billion by 2030, to grow at a CAGR of 11.5 % during the forecast period." Report Overview The latest research report titled Monoclonal Antibodies (Mabs) Market 2024: By Types, Applications, Size, Share, Key Players & Regions...0 Comments 0 Shares 641 Views 0 Reviews
-
Monoclonal Antibodies is Expected to Showcase a CAGR Of 9% due to the rising patent expiration| Univdatos Market InsightsAccording to a new report published by UnivDatos Markets Insights, the monoclonal antibodies market was valued at USD 180 billion in 2021 & is expected to grow at a CAGR of 9% from 2022-2028. The analysis has been segmented into Source (Chimeric, Human, Humanized, and Murine); Indication (Oncology, Autoimmune Diseases, Infectious Diseases, Inflammatory Diseases, and Others); End User...0 Comments 0 Shares 1K Views 0 Reviews
-
Monoclonal Antibodies Market Size, Share, Trends, Growth and Forecast 2023-2029Monoclonal antibodies market is experiencing significant growth, with a projected value of US$144,360 million by 2029 compared to US$105,790 million in 2022. This translates to a compound annual growth rate (CAGR) of 4.5% from 2023 to 2029. To Know more about this report (Description, TOC and List of Tables and Figures) — Monoclonal Antibodies Market This growth is driven by several...0 Comments 0 Shares 866 Views 0 Reviews
-
Protein A Resin: Effective Tool for Purification of Monoclonal AntibodiesOverview of Protein A Resin TechnologyProtein A resin is a popular chromatographic media used for the affinity purification of monoclonal antibodies. The resin utilizes the affinity of recombinant Protein A, which is derived from Staphylococcus aureus, for the Fc region of immunoglobulin G (IgG). When monoclonal antibody molecules, produced by mammalian cell culture, are loaded onto a Protein A...0 Comments 0 Shares 442 Views 0 Reviews
-
Innovations and Market Trends in Multiple Myeloma TherapiesThe Changing Landscape of Multiple Myeloma Therapies Multiple Myeloma , a malignant plasma cell disorder, has long been challenging to treat due to its complex pathology and the varying responses to therapy. Over recent years, the Multiple Myeloma therapies market has seen significant transformations driven by advances in understanding the disease, novel drug development, and evolving...0 Comments 0 Shares 575 Views 0 Reviews
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek